» Authors » Tomoyuki Nishikawa

Tomoyuki Nishikawa

Explore the profile of Tomoyuki Nishikawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 550
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Nakagami H, Nishikawa T, Tamura N, Maeda A, Hibino H, Mochizuki M, et al.
J Cell Mol Med . 2011 Aug; 16(7):1629-39. PMID: 21812915
We previously identified a novel angiogenic peptide, AG30, with antibacterial effects that could serve as a foundation molecule for the design of wound-healing drugs. Toward clinical application, in this study...
22.
Watanabe K, Iwata Y, Adachi S, Nishikawa T, Yoshida Y, Kameda S, et al.
J Org Chem . 2010 Aug; 75(16):5573-9. PMID: 20704431
The lactonamycin model aglycon 4 was synthesized from the trihalogenated benzene derivative 10. Ethynyltetraol 6 was prepared from 10 via carbon elongations, oxidative demethylation, a cycloaddition reaction with the diene...
23.
Nishikawa T, Nakagami H, Maeda A, Morishita R, Miyazaki N, Ogawa T, et al.
J Cell Mol Med . 2008 Apr; 13(3):535-46. PMID: 18410525
The utility of various synthetic peptides has been investigated in clinical trials of the treatment of cancers, infectious diseases and endocrine diseases. In the process of functional gene screening with...
24.
Hayashi H, Nakagami H, Takami Y, Sato N, Saito Y, Nishikawa T, et al.
Biochem Biophys Res Commun . 2007 Sep; 363(3):584-90. PMID: 17888873
gamma-Secretase cleaves the transmembrane domains of several integral membrane proteins involved in vasculogenesis. Here, we investigated the role of gamma-secretase in the regulation of postnatal angiogenesis using gamma-secretase inhibitors (GSI)....
25.
Takami Y, Nakagami H, Morishita R, Katsuya T, Cui T, Ichikawa T, et al.
Arterioscler Thromb Vasc Biol . 2007 Aug; 27(10):2184-90. PMID: 17690318
Objective: We identified a ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) gene, which encodes a deubiquitinating enzyme and is expressed in the vasculature, by functional screening of a human endothelial cell (EC)...
26.
Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H, et al.
Circulation . 2006 Sep; 114(11):1177-84. PMID: 16952986
Background: Lymphedema is a disorder of the lymphatic vascular system characterized by impaired lymphatic return and swelling of the extremities. Treatment for this disabling condition remains limited and largely ineffective....
27.
Nishikawa T, Nakagami H, Matsuki A, Maeda A, Yo C, Harada T, et al.
Hum Gene Ther . 2006 Apr; 17(4):470-5. PMID: 16610935
Isolation of effective therapeutic genes is critical for the advancement of gene therapy for various diseases, including vascular diseases and cancers. The goal of the present study was to screen...
28.
Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, et al.
Arterioscler Thromb Vasc Biol . 2005 Oct; 25(12):2542-7. PMID: 16224047
Objective: The delivery of autologous progenitor cells into ischemic tissue of patients is emerging as a novel therapeutic option. Here, we report the potential impact of cultured adipose tissue-derived cells...
29.
Nakagami H, Morishita R, Nishikawa T, Shimizu H, Iguchi S, Matsumoto K, et al.
Hypertens Res . 2004 Jun; 27(5):359-65. PMID: 15198484
Bag-1 is a novel multifunctional protein. It was identified based on its ability to bind the anti-apoptotic protein, bcl-2, and also reported to interact with the heat shock protein 70...
30.
Kaneda Y, Nakajima T, Nishikawa T, Yamamoto S, Ikegami H, Suzuki N, et al.
Mol Ther . 2002 Aug; 6(2):219-26. PMID: 12161188
We have developed a simple method for converting the lipid envelope of an inactivated virus to a gene transfer vector. Hemagglutinating virus of Japan (HVJ; Sendai virus) envelope vector was...